Bydureon Archives - Desang Diabetes Services

Dulaglutide — new Lilly injectable

30/11/2012 No Comments

Eli Lilly & Co says its once-weekly injectible drug, dulaglutide, has outperformed three other widely taken drugs in three just-concluded Phase III studies. According to

FDA Approves Bydureon once-weekly treatment for Type 2 diabetes

19/06/2012 No Comments

Recently approved T2 treatment Bydureon is becoming available in pharmacies in the USA nationwide this month. The approval was in part based on clinical experience

Dulaglutide — new Lilly injectable

FDA Approves Bydureon once-weekly treatment for Type 2 diabetes

Latest tweets

Recent posts

FDA approves cellular therapy for patients with Type 1 diabetes

CellTrans wins FDA approval for first cell therapy that treats Type 1 diabetes

Beta Bionics $100m to challenge for automated insulin dosing market